Klaus Felix

2.1k total citations
45 papers, 1.3k citations indexed

About

Klaus Felix is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Klaus Felix has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Klaus Felix's work include Pancreatic and Hepatic Oncology Research (18 papers), Pancreatitis Pathology and Treatment (10 papers) and Neuroendocrine Tumor Research Advances (8 papers). Klaus Felix is often cited by papers focused on Pancreatic and Hepatic Oncology Research (18 papers), Pancreatitis Pathology and Treatment (10 papers) and Neuroendocrine Tumor Research Advances (8 papers). Klaus Felix collaborates with scholars based in Germany, United States and Japan. Klaus Felix's co-authors include Matthias M. Gaida, Nathalia A. Giese, Jörg Kleeff, Markus W. Büchler, Hany Kayed, Helmut Friess, Daniel Hartmann, Thilo Hackert, Martina Schnölzer and Ivane Abiatari and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Klaus Felix

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Felix Germany 19 574 541 290 237 194 45 1.3k
Tatsuhiro Yoshiki Japan 21 550 1.0× 246 0.5× 248 0.9× 245 1.0× 115 0.6× 68 1.3k
Hanibal Bohnenberger Germany 22 690 1.2× 428 0.8× 196 0.7× 238 1.0× 287 1.5× 86 1.6k
Andreas-Claudius Hoffmann Germany 22 574 1.0× 584 1.1× 302 1.0× 440 1.9× 55 0.3× 53 1.3k
E. Ioachim Greece 24 674 1.2× 492 0.9× 375 1.3× 317 1.3× 109 0.6× 79 1.7k
Xiaodong Tan China 24 881 1.5× 555 1.0× 158 0.5× 599 2.5× 157 0.8× 88 1.5k
Yotis A. Senis United Kingdom 28 776 1.4× 249 0.5× 186 0.6× 175 0.7× 552 2.8× 65 2.2k
Irina Kusmartseva United States 15 474 0.8× 274 0.5× 478 1.6× 156 0.7× 144 0.7× 41 1.3k
Jeffrey A. Borgia United States 22 760 1.3× 378 0.7× 110 0.4× 339 1.4× 132 0.7× 104 1.5k
Federico Tozzi United States 11 714 1.2× 542 1.0× 193 0.7× 428 1.8× 88 0.5× 15 1.3k
Martin Schlesinger Germany 20 586 1.0× 590 1.1× 118 0.4× 287 1.2× 242 1.2× 40 1.4k

Countries citing papers authored by Klaus Felix

Since Specialization
Citations

This map shows the geographic impact of Klaus Felix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Felix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Felix more than expected).

Fields of papers citing papers by Klaus Felix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Felix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Felix. The network helps show where Klaus Felix may publish in the future.

Co-authorship network of co-authors of Klaus Felix

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Felix. A scholar is included among the top collaborators of Klaus Felix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Felix. Klaus Felix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bauer, Andrea S., Jean‐Louis Frossard, Masaru Yoshida, et al.. (2020). Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach. International Journal of Molecular Sciences. 21(7). 2403–2403. 11 indexed citations
3.
Schimmack, Simon, Yongchao Yang, Klaus Felix, et al.. (2019). C-reactive protein (CRP) promotes malignant properties in pancreatic neuroendocrine neoplasms. Endocrine Connections. 8(7). 1007–1019. 17 indexed citations
4.
Giese, Thomas, Andrea S. Bauer, Matthias M. Gaida, et al.. (2018). Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer. Oncotarget. 9(14). 11734–11751. 23 indexed citations
5.
Giese, Nathalia A., Thilo Hackert, Oliver Strobel, et al.. (2018). Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10. Journal of Cancer. 9(4). 711–725. 36 indexed citations
6.
Gaida, Matthias M., Hans Acha‐Orbea, Jean‐Louis Frossard, et al.. (2017). Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma. Journal of Translational Medicine. 15(1). 126–126. 12 indexed citations
7.
Staveski, Sandra, Marina Casazza, Eric Bair, et al.. (2016). Silver-Impregnated Dressings for Sternotomy Incisions to Prevent Surgical Site Infections in Children. American Journal of Critical Care. 25(5). 402–408. 9 indexed citations
8.
Felix, Klaus & Matthias M. Gaida. (2016). Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression. International Journal of Biological Sciences. 12(3). 302–313. 83 indexed citations
9.
Felix, Klaus, Sophie Dobiasch, Matthias M. Gaida, et al.. (2015). Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels. Pancreas. 45(7). 1048–1055. 5 indexed citations
10.
Strobel, Oliver, Klaus Felix, Thilo Hackert, et al.. (2015). Isolation and culture of primary human pancreatic stellate cells that reflect the context of their tissue of origin. Langenbeck s Archives of Surgery. 401(1). 89–97. 9 indexed citations
11.
Felix, Klaus, et al.. (2014). Objective parameters aid the prediction of fistulas in pancreatic surgery. Experimental and Therapeutic Medicine. 8(3). 719–726. 7 indexed citations
12.
Gaida, Matthias M., Thomas Steffen, F. A. Günther, et al.. (2012). Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase‐mediated degradation of E‐cadherin in pancreatic tumors. European Journal of Immunology. 42(12). 3369–3380. 69 indexed citations
13.
Hartwig, Werner, Alexandra M. Schmidt, Klaus Felix, et al.. (2012). Growth Inhibition of Pancreatic Cancer by Experimental Treatment With 4-Phenylbutyrate Is Associated With Increased Expression of Connexin 43. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(2). 103–111. 10 indexed citations
14.
Honda, Kazufumi, Takuji Okusaka, Klaus Felix, et al.. (2012). Altered Plasma Apolipoprotein Modifications in Patients with Pancreatic Cancer: Protein Characterization and Multi-Institutional Validation. PLoS ONE. 7(10). e46908–e46908. 42 indexed citations
15.
Felix, Klaus, Daniel Hartmann, Nathalia A. Giese, et al.. (2010). Identification of serum proteins involved in pancreatic cancer cachexia. Life Sciences. 88(5-6). 218–225. 45 indexed citations
16.
Felix, Klaus, et al.. (2010). New pre-analytical approach for the deep proteome analysis of sera from pancreatitis and pancreas cancer patients. Archives of Physiology and Biochemistry. 116(4-5). 208–217. 11 indexed citations
17.
Fiedler, Martin, Alexander Leichtle, Julia Kase, et al.. (2009). Serum Peptidome Profiling Revealed Platelet Factor 4 as a Potential Discriminating Peptide Associated with Pancreatic Cancer. Clinical Cancer Research. 15(11). 3812–3819. 91 indexed citations
18.
Abiatari, Ivane, Iréne Esposito, Tiago De Oliveira, et al.. (2009). MOESIN DEPENDENT CYTOSKELETON REMODELING IS ASSOCIATED WITH AN ANAPLASTIC PHENOTYPE OF PANCREATIC CANCER. Journal of Cellular and Molecular Medicine. 14(5). 1166–79. 33 indexed citations
19.
Ehmann, Michael R., Klaus Felix, Daniel Hartmann, et al.. (2007). Identification of Potential Markers for the Detection of Pancreatic Cancer Through Comparative Serum Protein Expression Profiling. Pancreas. 34(2). 205–214. 124 indexed citations
20.
Kayed, Hany, Jörg Kleeff, Armin Kolb, et al.. (2005). FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. International Journal of Cancer. 118(1). 43–54. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuhiro Yoshiki Breakdown of academic impact, for papers by Hanibal Bohnenberger Breakdown of academic impact, for papers by Andreas-Claudius Hoffmann Breakdown of academic impact, for papers by E. Ioachim Breakdown of academic impact, for papers by Xiaodong Tan Breakdown of academic impact, for papers by Yotis A. Senis Breakdown of academic impact, for papers by Irina Kusmartseva Breakdown of academic impact, for papers by Jeffrey A. Borgia Breakdown of academic impact, for papers by Federico Tozzi Breakdown of academic impact, for papers by Martin Schlesinger
Rankless by CCL
2026